SCHEMBL4422152

SCHEMBL4422152

C=CCOC[C@H]1CCCN(CC2CCCCC2NC(=O)O)C1

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CCR3 P51677 20/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4424743 1.00 CCR3 (0.43) CCR3
SCHEMBL14368831 0.86 CCR3 (0.41) CCR3
SCHEMBL14394247 0.86 CCR3 (0.41) CCR3
SCHEMBL14392609 0.86 CCR3 (0.41) CCR3
SCHEMBL4434042 0.85 CCR3 (0.47) CCR3
SCHEMBL14368945 0.85 CCR3 (0.37) CCR3
SCHEMBL14368952 0.85 CCR3 (0.37) CCR3
SCHEMBL14368942 0.83 CCR3 (0.43) CCR3
SCHEMBL14368938 0.83 CCR3 (0.49) CCR3
SCHEMBL14392669 0.83 CCR3 (0.43) CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2024359-A1 COMPOUNDS THAT ARE AGONISTS OF MUSCARINIC RECEPTORS AND THAT MAY BE EFFECTIVE IN TREATING PAIN, ALZHEIMER'S DECEASE AND/OR SCHIZOPHRENIA AstraZeneca AB (SE) 2009-02-18 — — EP disclosed
WO-2007126362-A1 COMPOUNDS THAT ARE AGONISTS OF MUSCARINIC RECEPTORS AND THAT MAY BE EFFECTIVE IN TREATING PAIN, ALZHEIMER'S DISEASE AND/OR SCHIZOPHRENIA ASTRAZENECA AB (SE) 2007-11-08 — — WO disclosed
Send feedback